Cargando…

HIV therapy in an ageing population — the challenge of polypharmacy

Detalles Bibliográficos
Autor principal: Back, DJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112839/
http://dx.doi.org/10.1186/1758-2652-13-S4-O26
_version_ 1782205829221449728
author Back, DJ
author_facet Back, DJ
author_sort Back, DJ
collection PubMed
description
format Online
Article
Text
id pubmed-3112839
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31128392011-06-13 HIV therapy in an ageing population — the challenge of polypharmacy Back, DJ J Int AIDS Soc Oral Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3112839/ http://dx.doi.org/10.1186/1758-2652-13-S4-O26 Text en Copyright ©2010 Back; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Back, DJ
HIV therapy in an ageing population — the challenge of polypharmacy
title HIV therapy in an ageing population — the challenge of polypharmacy
title_full HIV therapy in an ageing population — the challenge of polypharmacy
title_fullStr HIV therapy in an ageing population — the challenge of polypharmacy
title_full_unstemmed HIV therapy in an ageing population — the challenge of polypharmacy
title_short HIV therapy in an ageing population — the challenge of polypharmacy
title_sort hiv therapy in an ageing population — the challenge of polypharmacy
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112839/
http://dx.doi.org/10.1186/1758-2652-13-S4-O26
work_keys_str_mv AT backdj hivtherapyinanageingpopulationthechallengeofpolypharmacy